Angiogenesis inhibitors in clinical development for lung cancer
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 29 (1), 66-77
- https://doi.org/10.1053/sonc.2002.31527
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Alpha v integrin antagonists induce the disassembly of focal contacts in melanoma cellsEuropean Journal of Cell Biology, 2000
- ROLE OF MATRIX METALLOPROTEINASE-9 IN THE BASEMENT MEMBRANE DESTRUCTION OF SUPERFICIAL UROTHELIAL CARCINOMASJournal of Urology, 1999
- 2-Methoxyestradiol, an Endogenous Metabolite of Estrogen, Enhances Apoptosis and β-Galactosidase Expression in Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1998
- Suppression of type II collagen‐induced arthritis by the endogenous estrogen metabolite 2‐methoxyestradiolArthritis & Rheumatism, 1997
- The endogenous estrogen metabolite 2-methoxyestradiol induces apoptotic neuronal cell death in vitroLife Sciences, 1996
- Microvessel count predicts metastatic disease and survival in non‐small cell lung cancerThe Journal of Pathology, 1995
- Angiogenesis: An indicator of metastasis in non-small cell lung cancer invading the thoracic inletThe Annals of Thoracic Surgery, 1994
- The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growthNature, 1994
- Carcinogenicity of catechol estrogens in Syrian hamstersJournal of Steroid Biochemistry, 1986
- Heterologous, homologous, and autologous transplantation of human tumorsCancer, 1963